Nextech Invest Ltd. Long-Term Concentrated

Location: Zurich, Switzerland

CIK: 0001595430 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $1.034B (100.0% shares, 0.0% debt)

Holdings (16)

RVMD REVOLUTION MEDICINES INC 58.5%
Value $605M Shares 7,601,087 Est. Cost $40.59 Unrealized +61.5%
TYRA TYRA BIOSCIENCES INC 10.3%
Value $107M Shares 4,055,861 Est. Cost $12.94 Unrealized +41.9%
TNGX TANGO THERAPEUTICS INC 6.2%
Value $64.38M Shares 7,266,081 Est. Cost $3.92 Unrealized +119.6%
ORIC ORIC PHARMACEUTICALS INC 5.7%
Value $58.59M Shares 7,162,637 Est. Cost $8.21 Unrealized +40.2%
RLAY RELAY THERAPEUTICS INC 3.8%
Value $39.77M Shares 4,701,506 Est. Cost $4.50 Unrealized +58.5%
ZYME ZYMEWORKS INC 2.8%
Value $29.33M Shares 1,113,946 Est. Cost $13.64 Unrealized +59.9%
ALMS ALUMIS INC 2.8%
Value $28.46M Shares 2,915,998 Est. Cost $5.28 Unrealized +32.3%
KYMR KYMERA THERAPEUTICS INC 2.1%
Value $21.7M Shares 278,896 Est. Cost $34.43 Unrealized +96.1%
ENGN ENGENE HOLDINGS INC 1.9%
Value $19.19M Shares 2,124,943 Est. Cost $8.01 Unrealized 0.0%
MERSANA THERAPEUTICS INC 1.3%
Value $13.96M Shares 482,689 Est. Cost $7.76 Unrealized
CGEM CULLINAN THERAPEUTICS INC 1.1%
Value $11.81M Shares 1,141,145 Est. Cost $9.60 Unrealized -6.0%
CNTX CONTEXT THERAPEUTICS INC 1.1%
Value $10.91M Shares 7,419,355 Est. Cost $0.87 Unrealized +34.2%
SPRY ARS PHARMACEUTICALS INC 0.7%
Value $7.697M Shares 660,703 Est. Cost $12.03 Unrealized -19.2%
ARVN ARVINAS INC 0.6%
Value $6.397M Shares 539,394 Est. Cost $15.67 Unrealized -30.3%
SLN SILENCE THERAPEUTICS PLC 0.6%
Value $5.791M Shares 952,400 Est. Cost $2.82 Unrealized
GLUE MONTE ROSA THERAPEUTICS INC 0.4%
Value $4.378M Shares 279,237 Est. Cost $13.48 Unrealized 0.0%